Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 23 11:12AM ET
0.7686
Dollar change
-0.0337
Percentage change
-4.20
%
Index- P/E- EPS (ttm)-13.33 Insider Own4.14% Shs Outstand0.99M Perf Week-13.64%
Market Cap0.76M Forward P/E0.08 EPS next Y9.99 Insider Trans292.78% Shs Float0.95M Perf Month-17.35%
Income-4.09M PEG- EPS next Q-2.00 Inst Own14.82% Short Float29.95% Perf Quarter-85.36%
Sales26.74M P/S0.03 EPS this Y99.95% Inst Trans-93.93% Short Ratio0.09 Perf Half Y-96.80%
Book/sh24.94 P/B0.03 EPS next Y100000.00% ROA-13.88% Short Interest0.28M Perf Year-98.82%
Cash/sh17.61 P/C0.04 EPS next 5Y- ROE-18.47% 52W Range0.75 - 67.01 Perf YTD-97.17%
Dividend Est.- P/FCF- EPS past 5Y73.50% ROI-16.15% 52W High-98.85% Beta-1.05
Dividend TTM- Quick Ratio3.23 Sales past 5Y542.96% Gross Margin32.57% 52W Low2.48% ATR (14)0.45
Dividend Ex-Date- Current Ratio4.41 EPS Y/Y TTM89.16% Oper. Margin-15.02% RSI (14)30.78 Volatility13.26% 17.53%
Employees44 Debt/Eq0.02 Sales Y/Y TTM193.30% Profit Margin-15.29% Recom1.00 Target Price15.00
Option/ShortNo / Yes LT Debt/Eq0.02 EPS Q/Q74.09% Payout- Rel Volume0.93 Prev Close0.80
Sales Surprise25.90% EPS Surprise-66.67% Sales Q/Q54.09% EarningsMar 28 BMO Avg Volume3.02M Price0.77
SMA20-14.14% SMA50-81.32% SMA200-96.52% Trades Volume837,276 Change-4.20%
May-21-24 08:00AM
May-20-24 09:54PM
May-16-24 06:15AM
Apr-19-24 08:00AM
Apr-12-24 09:00AM
01:53PM Loading…
Apr-08-24 01:53PM
Apr-01-24 08:00AM
Mar-04-24 09:18AM
Feb-15-24 09:15AM
Feb-13-24 09:00AM
Dec-04-23 08:30AM
Nov-13-23 08:30AM
Sep-21-23 09:05PM
Aug-11-23 08:30AM
May-16-23 02:15PM
09:58AM Loading…
09:58AM
May-12-23 08:00AM
May-11-23 09:00AM
Apr-05-23 08:00AM
Feb-28-23 07:30AM
Feb-10-23 07:35AM
Jan-19-23 07:30AM
Dec-27-22 08:00AM
Dec-20-22 08:00AM
Nov-23-22 11:20AM
Nov-16-22 10:12AM
08:00AM
Nov-13-22 07:52AM
Nov-07-22 09:28AM
Oct-20-22 08:00AM
07:32AM Loading…
07:32AM
Aug-08-22 08:15AM
Aug-04-22 08:00AM
Jul-28-22 08:10AM
Jun-27-22 05:30AM
Apr-28-22 04:50PM
09:20AM
Apr-26-22 08:13AM
12:41AM
Apr-25-22 08:00AM
Apr-19-22 06:45PM
02:02PM
Apr-08-22 09:44AM
Apr-05-22 03:45PM
01:41PM
08:00AM
07:30AM
Mar-15-22 09:45AM
Mar-14-22 06:12PM
Mar-10-22 09:17AM
Feb-25-22 08:00AM
Feb-17-22 10:40AM
10:07AM
Feb-15-22 09:00AM
Dec-22-21 08:52AM
Nov-03-21 12:35PM
Oct-06-21 08:00AM
Aug-12-21 09:00AM
Jul-27-21 09:00AM
Jul-20-21 09:00AM
Jul-08-21 09:00AM
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Slilaty Steve N.Chief Executive OfficerMar 04 '24Buy0.10100,00010,000130,000Mar 05 04:05 PM
Slilaty Steve N.Chief Executive OfficerFeb 08 '24Buy0.1020,0002,00030,000Feb 12 04:05 PM